Salvar offers advanced air conditioning filters that capture and neutralize airborne pathogens and allergens within recirculated air. These patented filters integrate with existing HVAC systems to improve indoor air quality and reduce the transmission of respiratory illnesses.
Funding
Funding not disclosed
Founders
Product
Problem
HVAC systems in enclosed spaces recirculate air, potentially concentrating airborne pathogens and allergens. This recirculation can increase the risk of disease transmission and exacerbate respiratory conditions like allergies and rhinitis.
Solution
Salvar provides advanced air conditioning filters designed to enhance indoor air quality by capturing and neutralizing airborne contaminants. These filters integrate with existing HVAC systems, acting as a barrier against viruses, bacteria, and allergens. By reducing the concentration of these particles in the recirculated air, Salvar contributes to healthier indoor environments and mitigates the spread of respiratory illnesses. The technology is patented and has undergone independent laboratory testing.
Target Audience
The primary target audience includes businesses, institutions, and individuals seeking to improve indoor air quality and reduce airborne disease transmission in environments utilizing air conditioning.
Features
- High-efficiency filtration technology capable of capturing up to 99.999% of viruses and bacteria.
- Patented chemical barrier integrated into the filter material for pathogen neutralization.
- Designed to be retrofitted onto existing air conditioning units, including Split, Window, and Cassette models.
- Available in multiple sizes (S1, S2, S3 for Splits; J1 for Window; K1 for Cassette) to accommodate various HVAC capacities (BTU ratings).
- Easy installation process requiring no specialized technical expertise.
- Reduces the incidence of allergic reactions and respiratory symptoms.
- Provides a collective protection measure for enclosed environments.